Skip to main content
. 2024 Jan 17;67(2):1225–1242. doi: 10.1021/acs.jmedchem.3c01714

Figure 2.

Figure 2

Clinical IRAK4 inhibitors from Pfizer, Inc. 1 and Curis, Inc.—Aurigene Discovery Technologies Ltd. 2 and representative examples taken from patent applications filed by Gilead Sciences, Inc. 3 and Rigel Pharmaceuticals 4.